Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.


PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms

VIEW PRESS RELEASE [PDF] 04 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson’s therapy in response to motor symptoms.  The allowed claims include a portable

Read more ›


PRESS RELEASE: GLNT Stimulates Job Growth in Northeast Ohio Biotechnology Market

VIEW PRESS RELEASE [PDF] 18 Oct 2012: Valley View, OH – In 2012, Great Lakes NeuroTechnologies has grown its workforce by 50%, bringing sustainable, high-tech jobs to Northeast Ohio.  Since 2006, the team at the biotech company has focused on developing innovative medical devices, specifically in the area of movement

Read more ›


PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS)

Read more ›


PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress in Dublin, Ireland.  The Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/  ] system

Read more ›


PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  These intellectual property claims

Read more ›


PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health’s SBIR program. Each project is focused on developing and

Read more ›


PRESS RELEASE: Cleveland Medical Devices Inc. spins off Great Lakes NeuroTechnologies

VIEW PRESS RELEASE [PDF] Cleveland, OH – March 23, 2011 – Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTechnologies (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as

Read more ›


PRESS RELEASE: FROST & SULLIVAN LAUDS CLEVEMED FOR KINESIA™, A REVOLUTIONARY MOBILITY DISORDER MONITORING SYSTEM

VIEW PRESS RELEASE [PDF] Palo Alto, Calif. – March 12, 2008 – Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American Product Innovation of the Year Award. This Award highlights CleveMed´s development of

Read more ›


PRESS RELEASE: CLEVEMED’S KINESIA DEVICE AWARDED NEUROTECH BUSINESS REPORT’S “GOLD ELECTRODE AWARD” FOR BEST NEW PRODUCT

VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (Nov. 20, 2007) – The Neurotech Business Report announced Friday, October 26 th at the 2007 Neurotech Leaders Forum in Newport Beach, CA that Cleveland Medical Devices Inc.’s (CleveMed) Kinesia TM Quantitative Motor Assessment System would receive the Gold Electrode Award for Best New

Read more ›